This information was published on 2024-11-28T04:23:02 for IP Right Filed Published.
| Field | Value |
| (210) | 2502579 (IR 1824942) |
| (220) |
06 May 2024
|
| (300) |
US, 07 Nov 2023, 98258262
|
| (511) (510) |
Class 5
Pharmaceutical preparations, formulations, or suspensions for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, embolic particles; pharmaceutical preparations for embolization therapy. Class 10 Medical apparatus and instruments for embolization; embolic devices for treating anomalies vasculature of the body; medical device, namely, vascular embolization device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated particle embolics (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device for vascular embolization procedures; organ ischemia or infarction interventions (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations, or occlusion of blood flow in the peripheral vasculature; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of embolic particles therefore (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical apparatus, namely, system for vascular embolization procedures; embolic devices and kits for vascular embolization and peripheral hemostasis, namely, embolization therapy system, featuring embolic particles. |
| (540) | EMBARC |
| (550) | Word |
| (730) |
Instylla, Inc.
|
Find out more about publications on the About page.